AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
150 hedge funds and large institutions have $1.28B invested in Aerie Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 61 increasing their positions, 54 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
36% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 25
Holders
150
Holding in Top 10
6
Calls
$6.69M
Puts
$3.52M
Top Buyers
| 1 | +$28.4M | |
| 2 | +$26.5M | |
| 3 | +$24.8M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$22.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$20.9M |
Top Sellers
| 1 | -$46.7M | |
| 2 | -$20.1M | |
| 3 | -$13.7M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$13.5M |
| 5 |
WC
Weatherbie Capital
Boston,
Massachusetts
|
-$10.1M |